Project Grant K12TR005468

The National Center for Advancing Translational Sciences awarded Georgetown University $752,548 on September 1, 2026, under the CTSA K12 Program (CFDA 93.350) to support clinical and translational science training and career development for early-stage investigators.

Georgetown University operates the K12 program as part of the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a partnership that includes Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory. The program recruits and trains early-stage investigators across 50 departments throughout GHUCCTS to build careers as independent researchers, national leaders, and mentors in clinical and translational science (CTS). Over the past fifteen years, prior KL2 alumni have authored 1,070 scientific papers, secured 62 successful extramural grants, and launched 30 successful sponsored clinical trials, achieving an 84 percent success rate on extramural grant awards compared to a national CTSA average of approximately 60 percent.

The three primary objectives are to extend training in CTS to scholars across multiple disciplines through expanded recruitment efforts, prime outstanding early-stage investigators for independent research careers, and conduct continuous quality improvement studies of the K12 program. Work is performed in Washington, DC. The period of performance runs from September 1, 2026, through August 31, 2031.